Anzeige
Mehr »
Login
Donnerstag, 28.03.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Spezial am Donnerstag: Rallye II. - Neuer Anstoß, News und was die Börsencommunity jetzt nicht verpassen will…
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QD9S | ISIN: HK0000658531 | Ticker-Symbol: S2P
Stuttgart
28.03.24
10:34 Uhr
0,620 Euro
0,000
0,00 %
Branche
Pharma
Aktienmarkt
ASIEN
1-Jahres-Chart
SIMCERE PHARMACEUTICAL GROUP LTD Chart 1 Jahr
5-Tage-Chart
SIMCERE PHARMACEUTICAL GROUP LTD 5-Tage-Chart
RealtimeGeldBriefZeit
0,6150,64022:36
0,6100,64522:00

Aktuelle News zur SIMCERE PHARMACEUTICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrSIMCERE PHARMA (02096): NEXT DAY DISCLOSURE RETURN1
21.03.SIMCERE PHARMA (02096): LETTER TO NON-REGISTERED SHAREHOLDERS - ARRANGEMENT OF ELECTRONIC DISSEMINATION OF CORPORATE COMMUNICATIONS AND REPLY FORM-
21.03.SIMCERE PHARMA (02096): LETTER TO REGISTERED SHAREHOLDERS - ARRANGEMENT OF ELECTRONIC DISSEMINATION OF CORPORATE COMMUNICATIONS AND REPLY FORM-
21.03.SIMCERE PHARMA (02096): ELECTION OF MEANS OF RECEIPT OF CORPORATE COMMUNICATIONS1
21.03.SIMCERE PHARMA (02096): GRANT OF AWARDS UNDER THE 2021 RSU SCHEME1
21.03.China's Simcere Pharma jumps on profit growth, share buyback hike1
20.03.SIMCERE PHARMA (02096): VOLUNTARY ANNOUNCEMENT - SHARE REPURCHASE1
20.03.SIMCERE PHARMA (02096): FINAL DIVIDEND FOR THE YEAR ENDED DECEMBER 31, 20231
20.03.SIMCERE PHARMA (02096): ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 20231
20.03.SIMCERE PHARMA (02096): ADOPTION OF EQUITY INCENTIVE SCHEME BY SIMCERE ZAIMING AND CONNECTED TRANSACTION IN RELATION TO CAPITAL CONTRIBUTIONS IN SIMCERE ...-
15.03.SIMCERE PHARMA (02096): VOLUNTARY ANNOUNCEMENT - NEW DRUG APPLICATION OF SUVEMCITUG FOR INJECTION ACCEPTED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION-
12.03.SIMCERE PHARMA (02096): VOLUNTARY ANNOUNCEMENT - THE CLINICAL TRIAL APPROVAL FOR SIM0500 FOR INJECTION (A HUMANIZED GPRC5D-BCMA-CD3 TRISPECIFIC ANTIBODY) ...1
08.03.SIMCERE PHARMA (02096): DATE OF BOARD MEETING2
01.03.Profit setback for Simcere Pharma in novel drugs quest1
21.02.Simcere Pharmaceutical Group Limited: Findings of a Phase III Clinical Study of Sanbexin Sublingual Tablets Published in JAMA124NANJING, China, Feb. 20, 2024 /PRNewswire/ -- On February 19, 2024, the Journal of American Medical Association•Neurology (JAMA NEUROLOGY, IF: 29.0) published online the key findings of a phase...
► Artikel lesen
20.02.SIMCERE PHARMA (02096): VOLUNTARY ANNOUNCEMENT - PUBLICATION BY JAMA NEUROLOGY ABOUT THE PHASE III CLINICAL STUDIES RESULTS OF SANBEXIN SUBLINGUAL TABLETS ...1
05.02.SIMCERE PHARMA (02096): NEXT DAY DISCLOSURE RETURN 3
19.01.FAST NEWS: Simcere's Covid drug trial shows promising results4
18.01.SIMCERE PHARMA (02096): VOLUNTARY ANNOUNCEMENT - PUBLICATION BY THE NEW ENGLAND JOURNAL OF MEDICINE ABOUT THE PHASE II/III CLINICAL STUDIES RESULTS OF ...1
17.01.SIMCERE PHARMA (02096): FURTHER ANNOUNCEMENT ON THE CONTINUING CONNECTED TRANSACTION UNDER THE EXCLUSIVE PROMOTION SERVICES COOPERATION AGREEMENT-
Seite:  Weiter >>
53 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1